Evaluation of the optimal LNCaP prostate tumour developmental stage to be assessed by 99mTc-HYNIC-βAla-Bombesin(7-14) in an experimental model

Journal of Radioanalytical and Nuclear Chemistry

Volumn 300, Issue 2, 2014, Pages 801-807

  Fuscaldi, Leonardo Lima ^a   De Barros, André Luís Branco ^a   Santos, Caiubi Rodrigues De Paula ^a   De Souza, Cristina Maria ^a   Cassali, Geovanni Dantas ^a   De Oliveira, Mônica Cristina ^a   Fernandes, Simone Odília Antunes ^a   Cardoso, Valbert Nascimento ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bombesin; Histopathological analysis; LNCaP prostate tumour; Molecular imaging; Radiopeptide

Indexed keywords

2 HYDRAZINONICOTINAMIDE BETA ALANINE BOMBESIN[7-14] TC 99M; COLLAGEN FIBER; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; HISTOPATHOLOGY; IMAGE QUALITY; ISOTOPE LABELING; LNCAP CELL LINE; MOLECULAR IMAGING; NONHUMAN; PROSTATE TUMOR; SCINTIGRAPHY; STROMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 84899973387     PISSN: 02365731     EISSN: 15882780     Source Type: Journal    
DOI: 10.1007/s10967-014-3040-2     Document Type: Article

References (30)

1. Cancer incidence and mortality worldwide (2010) GLOBOCAN 2008 v2.0, Lyon. http://globocan.iarc.fr. Accessed 30 Jan 2013
2. Schottelius M, Wester H (2009) Molecular imaging targeting peptide receptors. Methods 48:161-177
3. Weiner RE, Thakur ML (2002) Radiolabeled peptides in the diagnosis and therapy of oncological diseases. Appl Radiat Isot 57:749-763 (Pubitemid 35279166)
4. Ferro-Flores G, Ramïrez FM, Melëndez-Alafort L, Santos-Cuevas CL (2010) Peptides for in vivo target-specific cancer imaging. Mini Rev Med Chem 10:87-97
5. de Barros ALB, Mota LG, Soares DCF, Coelho MMA, Oliveira MC, Cardoso VN (2011) Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification. Bioorg Med Chem Lett 21:7373-7375
6. 99mTc-labeled bombesin analog for breast cancer identification. J Radioanal Nucl Chem 295:2083-2090
7. 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. J Nucl Med 52:470-477
8. Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K, Borkowski S, Reubi JC, Maecke HR (2011) Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. Eur J Nucl Med Mol Imaging 38:97-107
9. Yu Z, Carlucci G, Ananias HJK, Dierckx RAJO, Liu S, Helfrich W, Wang F, de Jong IJ, Elsinga PH (2013) Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer. Amino Acids 44:543-553
10. Schroeder RPJ, van Weerden WM, Bangma C, Krenning EP, de Jong M (2009) Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues. Methods 48:200-204
11. 99mTc-EC-tyrosine for early detection of breast cancer tumor response to the anticancer drug melphalan. Acad Radiol 20:41-51
12. 99mTc-ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology 226:465-473
13. de Barros ALB, Mota LG, Ferreira CA, de Oliveira MC, de Góes AM, Cardoso VN (2010) Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification. Bioorg Med Chem Lett 20:6182-6184
14. (7-14). Appl Radiat Isot 70:2440-2445
15. 99mTc via hydrazinonicotinamide: description of optimized radiolabeling conditions. J Radioanal Nucl Chem 284:539-545
16. 99mTc-EDDA/ tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines. J Drug Target 21:383-388
17. Emonds KM, Swinnen JV, Mortelmans L, Mottaghy FM (2009) Molecular imaging of prostate cancer. Methods 48:193-199
18. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev 1:34-45 (Pubitemid 33741879)
19. Grigoryev DN, Long BJ, Njar VCO, Brodie AHM (2000) Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor. J Steroid Biochem Mol Biol 75:1-10 (Pubitemid 32155418)
20. Xie Y, Wolff DW, Lin M, Tu Y (2007) Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells. Mol Pharmacol 72:73-85 (Pubitemid 46998526)
21. Yu S, Lai K, Xia S, Chang H, Chang C, Yeh S (2009) The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian J Androl 11:39-48
22. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression. J Nucl Med 50:2017-2024
23. National Formulary (USP 34-NF 29) (2011) US Pharmacopeia
24. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818 (Pubitemid 13122588)
25. Chua TC, Yao P, Akther J, Morris DL (2010) Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy. Pathol Oncol Res 16:217-222
26. Jun HY, Yin H, Kim S, Park SH, Kim HS, Yoon K (2010) Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model. Korean J Radiol 11:449-456
27. Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE (2008) Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. PNAS 105:11305-11310
28. Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ (2008) Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nucl Med Biol 35:401-411 (Pubitemid 351637643)
29. (7-14)NH2 with favorable properties for SPECT imaging of colon cancer. Bioconjug Chem 19:1170-1178
30. Phillips WT (1999) Delivery of gamma-imaging agents by liposomes. Adv Drug Delivery Rev 37:13-32